While some reports suggest that CD4+ T cells may be potential prognostic markers and therapeutic targets for HCC treatment [8], other studies found no correlation between CD4+ T cells and HCC progression [9, 10]. This evidence concerns the gene CD4 and hepatocellular carcinoma.